1. Liu, Ting, Gu, Jingjing, Li, Chuning, Liu, Hanting, Zhang, Zhengdong. . Alternative polyadenylation-related genetic variants contribute to bladder cancer risk. In Journal of biomedical research, 37, 405-417. doi:10.7555/JBR.37.20230063. https://pubmed.ncbi.nlm.nih.gov/37936490/
2. Zhao, Dan, Zhang, Wei, Li, Xiao-guang, Chang, Qing-yun, Wu, Ling-ying. . [The mRNA expression of BRCA1, ERCC1, TUBB3, PRR13 genes and their relationship with clinical chemosensitivity in primary epithelial ovarian cancer]. In Zhonghua zhong liu za zhi [Chinese journal of oncology], 34, 196-200. doi:10.3760/cma.j.issn.0253-3766.2012.03.008. https://pubmed.ncbi.nlm.nih.gov/22780973/
3. Chi, Hua-Ming, Du, Jing-Dong, Cheng, Jie, Mao, Hua-Dong. 2019. Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells. In Medical science monitor : international medical journal of experimental and clinical research, 25, 475-483. doi:10.12659/MSM.913180. https://pubmed.ncbi.nlm.nih.gov/30650069/
4. Bi, Jingtao, Bai, Zhigang, Ma, Xuemei, Han, Shiwei, Zhang, Zhongtao. 2013. Txr1: an important factor in oxaliplatin resistance in gastric cancer. In Medical oncology (Northwood, London, England), 31, 807. doi:10.1007/s12032-013-0807-1. https://pubmed.ncbi.nlm.nih.gov/24362794/
5. Zhang, Huiming, Qu, Xiang, Ma, Xuemei, Yuan, Zhu, Wang, Zihan. 2016. TXR1 and TSP1 expression varies by the molecular subtypes of breast cancer patients who received previous docetaxel-based first-line chemotherapy. In Experimental biology and medicine (Maywood, N.J.), 241, 1919-1923. doi:. https://pubmed.ncbi.nlm.nih.gov/27407097/
智鼠故事 
